Mental Illness Chapter 22 PDF
Document Details
Uploaded by KindlyElegy
2024
Tags
Related
- ALU 201: Intermediate Medical Life Insurance Writing PDF
- Understanding Mental Health and Illness Review PDF
- Test Exam Review Understanding Mental Health and Illness PDF
- Test Bank for Varcarolis' Foundations of Psychiatric-Mental Health Nursing 9th Edition PDF
- Mental Health and Mental Illness 2024 PDF
- The Neuroscience of Clinical Psychiatry PDF
Summary
This document is lecture notes on mental illness. The document covers different aspects such as anxiety disorders, affective disorders, and schizophrenia. It explores the learning objectives, different approaches to mental illness.
Full Transcript
Mental Illness Chapter 22 Understand the historical context behind the study of mental illnesses Learning Learn about the three major types of psychiatric illnesses, their causes, and their current treatments: objectives Anxiety disorder...
Mental Illness Chapter 22 Understand the historical context behind the study of mental illnesses Learning Learn about the three major types of psychiatric illnesses, their causes, and their current treatments: objectives Anxiety disorders Affective (mood) disorders Schizophrenia Neurology Branch of medicine concerned with the diagnosis and treatment of nervous system disorders Neurological disorders Ranging from multiple sclerosis to aphasia Help illustrate the role of physiological processes in normal brain Neurology vs. function Psychiatry Psychiatry Branch of medicine concerned with the diagnosis and treatment of disorders that affect the mind or psyche Psychiatric disorders Anxiety disorders Affective disorders Schizophrenia Human behavior Can be thought of as the cumulative product of brain activity Brain Product of two mutually interacting factors Heredity Environment DNA determines individualism. Mental illness Health and illness along continuum of bodily function & the brain Mental illness Diagnosable disorder of thought, mood, or behavior that causes distress or impaired functioning Mental illness Earlier belief Disorders of the body (medical) & the brain Disorders of the mind (spiritual) Current belief Most disorders of mood, thought, and behavior have biological explanations. The brain was linked to “craziness” since long before even the Middle Ages Freud’s theory: mental illness: unconscious and conscious elements of psyche come into conflict Treat by unearthing hidden secrets of unconscious Psychosocial Skinner: Many behaviors are learned maladaptive responses to the approaches environment. Treat by “unlearning” through behavior to mental modification illness Psychosocial approaches to mental illness have sound neurobiological basis. Psychotherapy Verbal communication to help patients unravel psyche conflicts Good ol’ Sigmund Freud Former major disorder: general paresis of the insane Symptoms: mania, cognitive deterioration Cause: infection with Treponema pallidum (syphilis) Paul Ehrlich (1910) discovered treatment. Penicillin (1928) treatment Biological Other mental illnesses traced directly to biological causes. Examples: vitamin deficiency, HIV in brain, autoimmune response approaches to mental illness Syphilis’ effects on the brain Using genetic information to develop treatment Discovery of pathophysiology—may suggest biological processes Molecular Target with drug therapy medicine in Unique challenges of brain diseases Same diagnosis may arise from many psychiatry causes. Genetic complexity New approach: study the pathophysiology of neurons Fear Adaptive response to threatening situations Many fears innate and species-specific. Other fears learned Anxiety disorders Caused by inappropriate expression of fear Anxiety Most common of psychiatric disorders disorders Post-traumatic stress disorder (PTSD) Symptoms Disorders Increased anxiety Intrusive memories, dreams, or characterized flashbacks Irritability, emotional numbness by increased Obsessive-compulsive disorder (OCD) anxiety Obsessions: recurrent, intrusive thoughts, images, ideas, or impulses Compulsions: repetitive behaviors to reduce anxiety Genetic predisposition for many anxiety disorders Fear evoked by threatening stimulus: stressor Biological Manifested by stress response basis of Stimulus–response relationship strengthened (or weakened) by anxiety experience Stress response with the hypothalamic- disorders pituitary-adrenal axis Humoral response: corticotropin- releasing hormone (CRH) adrenocorticotropic hormone (ACTH) cortisol HPA axis Both amygdala & hippocampus regulate CRH neurons. Regulation of Amygdala projects to bed nucleus of the stria terminalis, which activates the HPA the HPA axis axis. by the Hippocampus deactivates the HPA axis. Glucocorticoid receptors amygdala & Feedback loop hippocampus Push–pull regulation Decrease in hippocampal volume in chronically anxious subjects Psychotherapy Anxiolytic medications Role of GABA Treatments Benzodiazepines for anxiety Makes cells much more sensitive to GABA disorders Serotonin-selective reuptake inhibitors (SSRIs) Target for new drugs: CRH receptors Effects of benzos on GABA receptors Recurrent depression Major depression Dysthymia Bipolar disorder, or manic-depressive disorder Recurrent, repeated episodes Type I: mania Type II: hypomania Affective (mood) disorders Incidence of affective disorders is higher in prolific creative people / accomplished artists 10x higher incidence of major depressive disorder 30x higher incidence of bipolar disorder Artistic output often cycles with mood states especially with mania/hypomania Hypomanic states may improve some cognitive processes / reduce inhibitions Affective (mood) disorders The monoamine hypothesis Deficit in central diffuse modulatory systems Studied by effects of drugs Reserpine Monoamine oxidase (MAO) inhibitors Imipramine Biological Monoamine hypothesis of mood disorders Treatment focus on central serotonergic and/or noradrenergic basis of synapses affective disorders The diathesis-stress hypothesis Genetic predisposition (diathesis), other stress factors Role of HPA axis – strong comorbidity with anxiety disorders Impact of CRH HPA function becomes hyperactive. Biological Glucocorticoid receptor gene expression regulated by early experience. basis of Anterior cingulate cortex dysfunction Resting-state metabolic activity in anterior cingulate cortex increased in affective depression. disorders Electroconvulsive therapy (ECT): localized electrical stimulation Unknown mechanism in relieving depression Affects temporal lobe Advantage: quick relief of depression, mania Adverse effect: loss of prior memories, impaired storage of new information Psychotherapy: Help patients overcome negative views. Treatments Effective for mild to moderate depression for affective Antidepressants: MAO inhibitors, tricyclics, and SSRIs disorders Lithium treatment for bipolar disorder Discovered by accident, as with many other psychiatric disorder treatments Mechanism for stabilizing mood completely unknown, but interferes with many 2nd messenger chemical cascades Treatments for affective disorders Effects of lithium on 5 patients’ moods Deep brain stimulation When severe depression fails to respond to other treatment Electrode implanted deep in the brain Region of anterior cingulate cortex (Brodmann’s area 25) Electrical stimulation decrease activity in brain circuits that are chronically overactive Treatments Immediate relief from depression Preliminary findings, brain surgery a treatment of last resort for affective disorders The most severe mental disorder—loss of contact with reality Positive symptoms Delusions, hallucinations Disorganized speech Grossly disorganized or catatonic behavior Negative symptoms Reduced expression of emotion, poverty of speech Difficulty initiating goal-directed behavior Schizophrenia Memory impairment Artwork from schizophrenic individual – look closely Primarily a genetic disorder Faulty genes vulnerability to environmental factors Associated with physical changes in the brain Larger ventricle-to-brain size ratio Other important physical changes in brain The dopamine hypothesis: psychotic episodes triggered by activation of dopamine receptors Biological Neuroleptic drugs—potent blockers of dopamine receptors basis of schizophrenia The glutamate hypothesis Observed behavioral effects of phencyclidine (PCP) and ketamine Neither affects dopaminergic transmission. Both affect synapses that use glutamate as a neurotransmitter. Inhibit NMDA receptors Hypothesis: Schizophrenia reflects diminished activation of NMDA Biological receptors in the brain basis of schizophrenia Drug therapy combined with psychosocial support Conventional neuroleptics, such as chlorpromazine and haloperidol, act at D2 Treatments receptors Reduce the positive symptoms of for schizophrenia schizophrenia Numerous side effects Like symptoms of Parkinson’s disease Tardive dyskinesia Newest focus of drug research NMDA receptor Impact of neuroscience on psychiatry Mental illness recognized as pathologic modifications of the brain Genes and environment play an important role, causes not fully Summary understood. Chemical synaptic transmission is affected by drugs. Unclear why therapeutic drug effects take weeks. Less known about how psychosocial treatments act on the brain. Areas of focus for each chapter: Brain regions / circuits involved in certain behaviors Exam #3 Important neurochemicals & hormones that affect behavioral change advice Where they are released as well, if they are released in the brain Effects of damage to brain regions involved in behaviors You may bring 1 index card of notes Questions?